Abstract
Previous studies have shown long-term and short-term exercise preconditioning protects against doxorubicin (DOX) cardiotoxicity. However, it is unclear to what extent exercise modality and DOX dosage may influence exercise-induced cardioprotection. PURPOSE: To determine whether the positive effects of short-term exercise preconditioning against DOX-induced cardiotoxicity are affected by exercise modality and DOX dose. METHODS: Male Sprague-Dawley rats were randomly assigned to sedentary (SED), wheel-run (WR), or treadmill-run (TM) groups. Animals in WR and TM participated in 5 days of either treadmill training or voluntary wheel-running. SED animals remained in their cages duration the 5 day period. After 5 days, animals were randomly assigned to receive 10 mg/kg DOX (SED + DOX10, WR + DOX10, TM + DOX10), 15 mg/kg DOX (SED + DOX15, WR + DOX15, TM + DOX15) or saline (SED + SAL, WR + SAL, TM + SAL). Following the exercise/sedentary period all animals then remained sedentary for 5 days after DOX/SAL treatments. Ex vivo left ventricular function was measured using an isolated working heart model. RESULTS: SED + DOX10, SED + DOX15, and TM + DOX15 had significantly lower left ventricular developed pressure (LVDP) (34%, 39% and 19%, respectively, P < 0.05). However, LVDP of TM + DOX10, WR + DOX10 and WR + DOX15 were not significantly different than SED + SAL (P > 0.05). In addition, maximal rate of left ventricular pressure development (+dP/dt) in SED + DOX10, SED + DOX15 and TM + DOX15 were significantly lower than SED + SAL (P < 0.05). This reduction in + dP/dt, however, was not observed in the TM + DOX10, WR + DOX10 and WR + DOX15. CONCLUSION: Short-term treadmill or voluntary wheel running attenuated DOX-induced early onset cardiac dysfunction in animals treated with 10mg/kg DOX. In contrast, only short-term voluntary wheel running protected against DOX-induced early onset cardiac dysfunction in animals treated with 15 mg/kg DOX. These data suggest that while both treadmill and voluntary wheel running can protect against DOX cardiotoxicity, wheel running appears to afford enhanced protection against at higher doses.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.